Stocks and Investing Stocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022

Charles Duncan Maintained (STOK) at Buy with Decreased Target to $38 on, May 26th, 2022


Published on 2024-10-27 21:18:59 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Stoke Therapeutics, Inc." (STOK) at Buy with Decreased Target from $68 to $38 on, May 26th, 2022.

Charles has made no other calls on STOK in the last 4 months.



There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Charles's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Charles


  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $40 on, Wednesday, March 16th, 2022
  • Suji Jeong of "Jefferies" Initiated at Strong Buy and Held Target at $50 on, Monday, January 31st, 2022

Contributing Sources